16
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What was the prevalence and clinical presentation of coronavirus disease 2019 among health care workers with self-reported fever or respiratory symptoms in 2 Dutch hospitals within 2 weeks after the first patient with coronavirus disease 2019 was detected in the Netherlands?

          Findings

          In this cross-sectional study that included 1353 health care workers with self-reported fever or respiratory symptoms, 6% were infected with severe acute respiratory syndrome coronavirus 2. Most health care workers with coronavirus disease 2019 experienced mild disease, and only 53% reported fever.

          Meaning

          The high prevalence of mild clinical presentations, frequently not including fever, suggests that the currently recommended case definition for suspected coronavirus disease 2019 should be used less stringently.

          Abstract

          This cross-sectional study examines the prevalence and clinical presentation of coronavirus disease 2019 among health care workers in the Netherlands with self-reported fever or respiratory symptoms.

          Abstract

          Importance

          On February 27, 2020, the first patient with coronavirus disease 2019 (COVID-19) was reported in the Netherlands. During the following weeks, at 2 Dutch teaching hospitals, 9 health care workers (HCWs) received a diagnosis of COVID-19, 8 of whom had no history of travel to China or northern Italy, raising the question of whether undetected community circulation was occurring.

          Objective

          To determine the prevalence and clinical presentation of COVID-19 among HCWs with self-reported fever or respiratory symptoms.

          Design, Setting, and Participants

          This cross-sectional study was performed in 2 teaching hospitals in the southern part of the Netherlands in March 2020, during the early phase of the COVID-19 pandemic. Health care workers employed in the participating hospitals who experienced fever or respiratory symptoms were asked to voluntarily participate in a screening for infection with the severe acute respiratory syndrome coronavirus 2. Data analysis was performed in March 2020.

          Main Outcomes and Measures

          The prevalence of severe acute respiratory syndrome coronavirus 2 infection was determined by semiquantitative real-time reverse transcriptase–polymerase chain reaction on oropharyngeal samples. Structured interviews were conducted to document symptoms for all HCWs with confirmed COVID-19.

          Results

          Of 9705 HCWs employed (1722 male [18%]), 1353 (14%) reported fever or respiratory symptoms and were tested. Of those, 86 HCWs (6%) were infected with severe acute respiratory syndrome coronavirus 2 (median age, 49 years [range, 22-66 years]; 15 [17%] male), representing 1% of all HCWs employed. Most HCWs experienced mild disease, and only 46 (53%) reported fever. Eighty HCWs (93%) met a case definition of fever and/or coughing and/or shortness of breath. Only 3 (3%) of the HCWs identified through the screening had a history of travel to China or northern Italy, and 3 (3%) reported having been exposed to an inpatient with a known diagnosis of COVID-19 before the onset of symptoms.

          Conclusions and Relevance

          Within 2 weeks after the first Dutch case was detected, a substantial proportion of HCWs with self-reported fever or respiratory symptoms were infected with severe acute respiratory syndrome coronavirus 2, likely as a result of acquisition of the virus in the community during the early phase of local spread. The high prevalence of mild clinical presentations, frequently not including fever, suggests that the currently recommended case definition for suspected COVID-19 should be used less stringently.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: found

          Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

            Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. Aim We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. Methods Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. Results The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive – Global (EVAg), a European Union infrastructure project. Conclusion The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Detection of SARS-CoV-2 in Different Types of Clinical Specimens

              This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify possible means of non-respiratory transmission.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                21 May 2020
                May 2020
                21 May 2020
                : 3
                : 5
                : e209673
                Affiliations
                [1 ]Department of Infection Control, Amphia Hospital, Breda, the Netherlands
                [2 ]Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
                [3 ]Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
                [4 ]Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
                [5 ]Department of Infection Control, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
                [6 ]Microvida Laboratory for Medical Microbiology, Bravis Hospital, Roosendaal, the Netherlands
                [7 ]Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
                [8 ]Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
                [9 ]Department of Virology, Erasmus Medical Center, Rotterdam, the Netherlands
                Author notes
                Article Information
                Accepted for Publication: April 24, 2020.
                Published: May 21, 2020. doi:10.1001/jamanetworkopen.2020.9673
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Kluytmans-van den Bergh MFQ et al. JAMA Network Open.
                Corresponding Author: Marjolein F. Q. Kluytmans-van den Bergh, PhD, Department of Infection Control, Amphia Hospital, PO Box 90158, 4800 RK Breda, the Netherlands ( marjoleinkluytmans@ 123456gmail.com ).
                Author Contributions: Dr Kluytmans-van den Bergh had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Kluytmans-van den Bergh, Buiting, Koopmans, Kluytmans.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Kluytmans-van den Bergh.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Kluytmans-van den Bergh, Kluytmans.
                Administrative, technical, or material support: Kluytmans-van den Bergh, Buiting, Pas, van den Bijllaardt, van Oudheusden, Verweij.
                Supervision: Buiting, Pas, Koopmans, Kluytmans.
                Conflict of Interest Disclosures: Dr Pas reported serving as a scientific advisory board consultant for Luminex from 2016 to 2019 and received travel reimbursement; her employer (Microvida Laboratory for Medical Microbiology, Bravis Hospital, Roosendaal, the Netherlands) received her advisory board consultancy fee. No other disclosures were reported.
                Additional Contributions: Anneke M. C. Bergmans, PhD (Microvida Laboratory for Medical Microbiology, Bravis Hospital, Roosendaal, the Netherlands), provided facility management and interpretation of laboratory tests. Harold Verbakel, BSc, and Wilma Ritmeester, BSc (Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands), provided facility management. Martijn van der Ent, BSc, and Meike Wennekes, BSc (Microvida Laboratory for Medical Microbiology, Bravis Hospital, Roosendaal, the Netherlands), provided technical support. Ingrid Aarts, BSc, Caroine Phiri, BSc, Petra van Esch, BSc, Rini Geurts, BSc, Astrid van Eersel, BSc, Henny Broeders, BSc, Helen van Raak, BSc, Ine Michelbrink, BSc, and Iris Geboers, BSc (Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands), provided technical support. They were not compensated beyond their salaries.
                Article
                zoi200403
                10.1001/jamanetworkopen.2020.9673
                7243090
                32437576
                3fb6b7da-96dc-4902-b467-f0c124f7c315
                Copyright 2020 Kluytmans-van den Bergh MFQ et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 30 March 2020
                : 24 April 2020
                Categories
                Research
                Original Investigation
                Online Only
                Infectious Diseases

                Comments

                Comment on this article